Abstract
Annual Review of Pharmacology and Toxicology
Vol. 47:
699-729
(Volume publication date February 2007)
(doi:10.1146/annurev.pharmtox.47.120505.105214)
First published online as a Review in Advance on September 29, 2006Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System John A. Dani1 and Daniel Bertrand21Department of Neuroscience, Menninger Department of Psychiatry & Behavioral Sciences, Program of Structural & Computational Biology & Molecular Biophysics, Baylor College of Medicine, Houston, Texas 77030; email: jdani@bcm.tmc.edu 2Department of Neuroscience, Centre Médical Universitaire, Geneva, Switzerland; email: Daniel.Bertrand@medecine.unige.ch Abstract Subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) are constructed from numerous subunit combinations that compose channel-receptor complexes with varied functional and pharmacological characteristics. Structural and functional diversity and the broad presynaptic, postsynaptic, and nonsynaptic locations of nAChRs underlie their mainly modulatory roles throughout the mammalian brain. Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, postsynaptic nAChRs contribute a small minority of fast excitatory transmission, and nonsynaptic nAChRs modulate many neurotransmitter systems by influencing neuronal excitability. Nicotinic receptors have roles in development and synaptic plasticity, and nicotinic mechanisms participate in learning, memory, and attention. Decline, disruption, or alterations of nicotinic cholinergic mechanisms contribute to dysfunctions such as epilepsy, schizophrenia, Parkinson's disease, autism, dementia with Lewy bodies, Alzheimer's disease, and addiction. Acronyms and Definitions *: wildcard place holder indicating that other subunits may contribute to the composition of this nAChR Aβ: amyloid-β Ach: acetylcholine AChBP: ACh binding protein AD: Alzheimer's disease Autosomal dominant nocturnal frontal lobe epilepsies (ADNFLE): this form of nAChR-based epilepsy exhibits seizures that originate in the frontal lobe and occur mainly during non-REM sleep DA: dopamine GABA: γ-aminobutyric acid LTD: long-term depression LTP: long-term potentiation nAChR: nicotinic acetylcholine receptor SNc: substantia nigra compacta STP: short-term potentiation TM1–4: Transmembrane domain 1 through 4 of a folded nAChR subunit VTA: ventral tegmental area Most recent citing papers (via CrossRef)A systems biology network model for genetic association studies of nicotine addiction and treatment Pharmacogenetics and Genomics 19(7):538-551 (2009) Nicotine-induced and depolarisation-induced glutamate release from hippocampus mossy fibre synaptosomes: two distinct mechanisms Journal of Neurochemistry 110(2):570-580 (2009) Presynaptic Regulation of Dopamine Transmission in Schizophrenia Schizophrenia Bulletin (2009) Defining pre-synaptic nicotinic receptors regulated by beta amyloid in mouse cortex and hippocampus with receptor null mutants Journal of Neurochemistry 109(5):1452-1458 (2009) Nicotine modulates GABAergic transmission to dopaminergic neurons in substantia nigra pars compacta Acta Pharmacologica Sinica 30(6):851-858 (2009)
|
|
|
Users who read this review also read:
| Neal L. Benowitz Annual Review of Pharmacology and Toxicology. Volume 49, Page 57-71, Feb 2009 Abstract
| Full Text
| PDF (139 KB)
|
Add to Favorites
| Related | |
| D S McGehee, and , L W Role Annual Review of Physiology. Volume 57, Page 521-546, Oct 1995 First Page
| PDF (926 KB)
|
Add to Favorites
| Related | |
| Geoffrey Burnstock Annual Review of Pharmacology and Toxicology. Volume 49, Page 1-30, Feb 2009 Abstract
| Full Text
| PDF (1274 KB)
|
Add to Favorites
| Related | |
| Annette E. Fleckenstein, Trent J. Volz, Evan L. Riddle, James W. Gibb, Glen R. Hanson Annual Review of Pharmacology and Toxicology. Volume 47, Page 681-698, Feb 2007 Abstract
| Full Text
| PDF (117 KB)
|
Add to Favorites
| Related | |
|
|